UniQure N.V.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Amsterdam Netherlands (1998)

Organization Overview

First Clinical Trial
2012
NCT02082860
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

UniQure Biopharma B.V.